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Accurate confidence intervals for risk
difference in meta-analysis with rare events
Tao Jiang1*† , Baixin Cao2 and Guogen Shan3*†

Abstract
Background: Meta-analysis provides a useful statistical tool to effectively estimate treatment effect from multiple
studies. When the outcome is binary and it is rare (e.g., safety data in clinical trials), the traditionally used methods may
have unsatisfactory performance.
Methods: We propose using importance sampling to compute confidence intervals for risk difference in
meta-analysis with rare events. The proposed intervals are not exact, but they often have the coverage probabilities
close to the nominal level. We compare the proposed accurate intervals with the existing intervals from the fixed- or
random-effects models and the interval by Tian et al. (2009).
Results: We conduct extensive simulation studies to compare them with regards to coverage probability and
average length, when data are simulated under the homogeneity or heterogeneity assumption of study effects.
Conclusions: The proposed accurate interval based on the random-effects model for sample space ordering
generally has satisfactory performance under the heterogeneity assumption, while the traditionally used interval
based on the fixed-effects model works well when the studies are homogeneous.
Keywords: Binary outcome, Confidence interval, Importance sampling, Meta-analysis, Rare events

Background
Meta-analysis is a useful statistical tool in medical
research to evaluate treatment effect by analyzing outcomes from multiple clinical trials. The estimated treatment effect from meta-analysis is always more reliable
and accurate than the estimate from one selected study
among the available studies. In early phase clinical trials to
study safety of a new drug, rare events are very common
[1]. In meta-analysis for such data, Vandermeer et al. [1]
pointed out that the traditionally used asymptotic point
estimates and confidence intervals could be substantially
different from the results using exact methods under the
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† Tao Jiang and Guogen Shan contributed equally to this work.
1
School of Statistics and Mathematics, and School of Business, Zhejiang
Gongshang University, Hangzhou, Zhejiang, China
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exact conditional framework [2]. It is well known that
asymptotic approaches often do not have satisfactory performance when outcome is extreme or sample size is
small.
Multiple methods have been developed for metaanalysis with rare events over decades [3, 4]. The fixedeffects models are conveniently used in practice, such
as the Mantel-Haenszel method [5]. When one or both
groups in a study have zero events, a continuity correction is often needed in order to estimate risk ratio or
odds ratio, but the traditional correction by adding 0.5
may lead to undesirable influence on the analysis results
as pointed out by Sweeting et al [6]. Later, they developed
a continuity correction method by adding a float value
based on the size of each group to improve the coverage probability. Multiple follow-up articles discussed this
issue whether or not a small value should be added to
studies with rare events in data analysis [7, 8]. Kuss et al.
[8] suggested using a beta-binomial model to avoid adding
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arbitrary values to each cell in data analysis. Recently, Tian
et al. [9] proposed a simple and effective method for confidence interval calculation without artificial continuity
correction. The confidence intervals from each study were
weighted to construct an overall interval from simulation
studies under the fixed-effects model. Their developed
confidence intervals were shown to have better coverages
when the events are rare, but the length of their intervals
could be much longer than others.
In contrast to fixed-effects models, the treatment effect
in the random-effects model is assumed to follow a normal distribution. DerSimonian and Laird [10] proposed a
random-effects model by including a random study effect
to account for the variation of study population or study
design. The statistical software R package meta can be
used to compute confidence intervals for the fixed-effects
model and random-effects model [11]. Recently, Bakbergenuly and Kulinskaya [12] suggested the generalized linear mixed models (GLMMs) in meta-analysis to include
the correlation between point estimate and its variance
estimate in data analysis.
The aforementioned exact conditional approach
assumes both marginal totals in each study fixed [2]. It
is reasonable to assume that the numbers of participant
in each treatment group are fixed. It is not usual that a
repeated study has the same total number of events as
the observed study. The exact one-sided limit by Buehler
[13] follows the study design with sample size in each
treatment group fixed [14–16]. However, it is too computationally intensive to generate all possible samples in
meta-analysis with binary outcome [17].
In this article, we propose using importance sampling to
construct confidence interval for risk difference in metaanalysis with rare events. We apply the importance sampling method described by Lloyd and Li [18] to compute
the profile confidence limit proposed by Kabaila and Lloyd
[19]. Importance sampling methods have been studied by
many researchers with regards to coverages of confidence
intervals [20, 21]. Importance sampling does not require
to enumerate all possible samples [19]. This approach simulates samples from the distribution estimated from the
observed data. Importance sampling has to be used in
conjunction with a designated statistic to order the limits
of simulated samples. We consider the existing intervals from the fixed-effects and random-effects models as
designated statistics in this article.
The rest of this article is organized as follows. In
“Methods” section, we describe the fixed-effects and
random-effects models to estimate confidence intervals
for risk difference. We then introduce importance sampling for interval calculation. In “Results” section, we
use an example from 18 schizophrenia clinical trials to
illustrate the application of the proposed intervals, and
then compare the proposed intervals with the existing inte
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rvals with regards to coverage probability and average length.
In “Conclusions” section, we provide some remarks on
data analysis for meta-analysis with rare events.

Methods
For meta-analysis with binary outcome, data can be organized in a K × 4 table, where K is the number of studies
(Table 1). Each row represents the results from a parallel
study with the number of events and the number of nonevents in the new treatment group and the control group,
respectively. Let the two treatment groups be indexed by 0
and 1 for the control and the new treatment, respectively.
Suppose Xijr is the number of participants having r events
from the treatment j in ith study, where i = 1, 2, · · · , K,
j = 0, 1, and r = 0, 1. For studies with rare events, Xij1 is
often very small. Let nij = Xij1 + Xij0 be the total number
of participants from the treatment j in the ith study, and
N1 = (n11 , n21 , · · · , nK1 ) and N0 = (n10 , n20 , · · · , nK0 )
be the sample sizes for the new treatment group and the
control group, respectively. Suppose pj is the event rate of
the treatment j. Given the sample size nij , the number of
responses among these participants, Xij1 , follows a binomial distribution, B(nij , pj ). We assume that each study is
independent from each other, and the two groups within
each study are independent from each other as well. The
parameter of interest here is the risk difference between
the treatment group and the control group,
 = p 1 − p0 .
We first review the existing methods to construct twosided confidence intervals for  in “Intervals based on
fixed or random-effects model” section, and then develop
accurate intervals in “Accurate intervals” section.
Intervals based on fixed or random-effects model

We first consider the fixed-effects model to calculate
confidence interval for . Under the study homogeneity
assumption, the treatment effect in each study is assumed
to be the same,
i = μ,
where μ is the treatment effect. In the ith study, the risk
difference i is estimated as
 i = p̂i1 − p̂i0 ,

Table 1 Data from K independent studies with binary outcome
Study

Treatment group

Control group

Events

Non-events

Events

Non-events

1

X111

X110

X121

X120

2

X211

X210

X221

X220

···

···

···

···

···

K

XK11

XK10

XK21

XK20
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where p̂ij = Xij1 /nij is the estimated rate of the treatment j in the ith study. The variance is estimated as
1 p̂ij (1−p̂ij )
s2i =
from two independent proportions.
j=0
nij
The weight for the ith study is
wi =

ni1 ni0
1
,

ni1 ni0
ni1 + ni0 K
i=1
ni1 +ni0

K

ni0
where i=1 nni1i1+n
is the factor to standardize the weight
K i0
values, with i=1 wi = 1. It is easy to show that wi is an
increasing function of ni1 (ni0 ) when ni0 (ni1 ) is fixed.

The overall weighted treatment effect using the fixedeffects model is calculated as
F =


K


i .
wi 

i=1

and its variance is estimated as
2 =
SE
F

K


w2i s2i .

i=1

F follows the standard
 SE
The standardized statistic /
normal distribution asymptotically when  = 0. Therefore, the asymptotic confidence interval for  based on
the fixed-effects model (the F interval) at the nominal level
of 100(1 − α)% is
F , 
F ),
 F − z1−α/2 SE
 F + z1−α/2 SE
CIF = (

(1)

where za is the ath quantile of the standard normal distribution.
In the observation of study heterogeneity which could
be caused by study population or study design or influential covariates, DerSimonian and Laird [10] proposed
using the random-effects model to include the study random effect in the model as
i = μ + ui ,
where ui is the deviation of the ith study from the population mean μ, and it follows a normal distribution. Let vi be
the weight of the ith study from the fitted random-effects
model. Then, the weighted treatment effect and its vari

2 = K v2 s2 , respec R = K vi 
 i , and SE
ance are 
R
i=1
i=1 i i
tively. It follows that the asymptotic confidence interval
for  using the random-effects model (the R interval) is
computed as
R , 
R ),
 R − z1−α/2 SE
 R + z1−α/2 SE
CIR = (

(2)

It can be seen that the difference between CIF and CIR
is the weights used in the treatment effect and its variance calculation. The F interval and the R interval can be
computed by using the function metabin from the statistical software package meta [11, 22]. In the metabin
function, we use MH.exact = TRUE in the option with no
continuity correction in the estimates.

Accurate intervals

Exact confidence limit by Buehler [13] for  is preferable,
but it is computationally intensive to save all the possible samples in meta-analysis with sample size nij fixed.
For this reason, we consider importance sampling (IS) to
construct accurate intervals for  by simulating samples
from the distribution estimated from the observed data to
make statistical inference. Importance sampling has been
applied to many important medical research areas that
often only have one nuisance parameter (e.g., the proportion difference in a parallel study [21, 23]). We extend
the application of IS to meta-analysis with multiple nuisance parameters in confidence interval calculation. The
intervals computed using importance sampling are accurate with coverage close to the nominal level. In addition,
importance sampling has the computational advantage
over exact methods [19].
The calculation of the IS intervals has to be used in
conjunction with a designated statistic for the interval
ordering. Let T be the considered designated statistic.
Suppose p0 = (p10 , p20 , · · · , pK0 ) is the probability vector of the control group, where pi0 is the probability of the
control group in the ith study. The accurate upper limit
based on the designated statistic T is computed as the
supremum of  such that
 α

G() = P T(Y) ≤ T(yobs ) | , p̂0 () > ,
2

(3)

where yobs is the observed data, Y is data from the simulated data set, and p̂0 () is the maximum likelihood
estimate of p0 given .
Suppose we simulate B data sets from independent
 ∗ and
binomial distributions with the probabilities using 
∗

p0 ( ) estimated from the observed data yobs . For studies
with double zeros, although their estimated risk differences are zero, sample sizes from such studies are still
valuable information in estimating the overall  and it
confidence intervals [24]. Sample sizes from all studies
including the ones with double zeros are used in the proposed method. The number of events are simulated from
binomial distributions with the probabilities of 
p0 (∗ ).
The designated statistic of each simulated data set
is computed, and compared with T(yobs ). The set of
T(Y) ≤ T(yobs ) equals to T (yobs ) = {Y : T(Y) ≤
T(yobs )}. Let the size of T (yobs ) be B1 with data: Y1 , · · · ,
YB1 . Then, the upper limit in Eq. 3 can be rewritten as the
supremum of  such that
1
α
f (Yb |,
p0 ())
1

> ,
G() =
∗
∗

B
2
f (Yb | ,
p0 ( ))
b=1

B

where f (Yb ) is the probability density function of Yb ,
which is a product of independent binomial distributions
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with parameters (nij , pij ) for the treatment j in the ith
study. For a given , numerical algorithms can be used
to find the maximum likelihood estimator of p0 () to
calculate 
G().
Similarly, the IS lower limit can be computed. It should
be noted that designated statistics from the same model
are used for the IS upper limit and the IS lower limit. For
example, the asymptotic upper limit from the fixed-effects
model is used as the designated statistic for the accurate upper limit, and then the lower limits from the same
model is used for the accurate lower limit. We refer this
accurate interval as the IS-F interval. When the asymptotic limits from the random-effects model are used as
the designated statistics, the computed accurate limits are
referred to be as the IS-R interval.
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the F interval, the R interval, the IS-F interval, the IS-R
interval, and the Tian interval. The nominal confidence
level is set as 95%. The sample sizes, nij , are assumed to be
the same as those in the aforementioned example, as N1
and N0 in Table 2. The number of responses Xij1 follows
a binomial distribution (nij , pij ). We simulate D = 1, 000
data for each configuration: Y1 , Y2 , · · · , and YD . For the
proposed IS intervals, we generate B = 2, 000 importance samples from the estimated distribution using each
simulated data.
Coverage probability is defined as the proportion of
the pre-specified risk difference  being included in the
confidence intervals:

1 
I  ∈ CI(Yd ) .
D
D

CP =

d=1

Results
We first use an example from 18 schizophrenia clinical trials to illustrate the application of the proposed accurate
intervals. In addition to the F interval, the R interval, the
IS-F interval, and the IS-R interval, We also include the
confidence interval for  by Tian [9] in the comparison
(referred to be as the Tian interval). Tian interval can be
computed by using their developed R function meta.exact
from the exactmeta function, without the mid-p value
approach. All data including studies with zero events are
used in the confidence interval calculation.
These 18 schizophrenia clinical trials reported the number of all-cause mortality for patients treated with the
long-acting injectable antipsychotics (LAI-AP) or the oral
antipsychotics (OAP) which is the control treatment here.
Data of these 18 trials are presented in Table 2, which was
provided by Efthimiou [25]. Out of a total of 3774 participants treated with the LAI-AP, 7 events were observed. In
the OAP group, there were 6 events recorded from a total
of 2145 participants in the control group. The naive estimates for all-cause mortality rates are 0.185% and 0.279%
in the LAI-AP group and the OAP group, respectively.
 and the 95% confiTable 3 presents the estimated 
dence interval for  using the five methods. The point
 from the R method is similar to the Tian
estimate of 
method, and they are larger than that from the F method.
It can be seen that the Tian interval is much wider than
others, and the asymptotic F or R intervals have shorter
lengths than the proposed accurate intervals. The upper
limits of the proposed accurate intervals are smaller than
those of other intervals. All the intervals contain zero.
Therefore, we fail to reject the null hypothesis that there is
no difference between the LAI-AP treatment and the OAP
treatment with regards to the all-cause mortality rate.
Simulation studies

We conduct extensive simulation studies to compare coverage probability and average length of the five intervals:

A confidence interval with the simulated interval being
closer to the nominal level is preferable. Average length is
defined as the average of all the lengths
AL =

D

CIupper (Yd ) − CIlower (Yd )
d=1

D

,

where CIlower and CIupper are the lower limit and the upper
limit of an interval. When two intervals are comparable with regards to coverage probability, the one with a
shorter average length outperforms the other.
Homogeneity of study effects

We first compare the coverage probabilities of the five
methods with fixed probabilities, p1 and p0 . For simplicity,
we assume a common rate in the control group, pi0 = p,
with p from 0.01% to 10%. The treatment probability is
pi1 = p + . For each configuration of (p, ), the coverage probabilities of these methods are computed, see
Fig. 1 when =0.005 and 0.05. It can be seen that the F
method has the coverage closer to the nominal level when
=0.005, except the case in which p is very low. As 
is increased to 0.05, the F interval, the IS-R interval, and
the IS-F interval have similar coverages when p is small.
The IS-F interval and the IS-R interval are conservative
when p is large. In this plot with  = 0.05, the Tian
interval and the R interval have the coverage probabilities
below the nominal level. Overall, the F interval has good
performance with regards to coverage when studies are
homogeneous and have common rates.
Given the number of nuisance probabilities, it is difficult to compare the performance of the five methods
under each configuration. With 18 studies and 5 considered probabilities, the number of possible configurations
is 536 , which is over 1025 . For this reason, we follow the
approach by Tian et al. [9] to compare the performance of
these methods by simulating the probabilities of the control group (p0 ) from uniform distributions: U(0, b), where
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Table 2 Data from 18 clinical trials comparing all-cause mortality rate of patients treated with long-acting injectable antipsychotics
(LAI-AP) or the oral antipsychotics (OAP) treatment as the control
LAI-AP group

OAP group

Sample sizes

Study

Events

Non-events

Events

Non-events

N1

N2

Kane 2012

1

268

0

134

269

134

Kane 2014

0

168

0

172

168

172

Meltzer 2015

0

415

1

206

415

207

Hirsch 1973

0

41

0

40

41

40

Jolley 1990

2

25

0

27

27

27

Odejide 1952

0

35

1

34

35

35

Rifkin 1977

0

23

1

21

23

22

Lauriello 2008

0

306

0

98

306

98

Berwaerts 2015

0

160

0

145

160

145

Fu 2015

2

162

0

170

164

170

Gopal 2010

0

221

0

135

221

135

Hough 2010

0

206

0

204

206

204

Kramer 2010

0

163

0

84

163

84

Nasrallah 2010

1

390

1

126

391

127

Pandinda 2010

1

487

0

164

488

164

Takahasji 2013

0

160

1

163

160

164

Kane 2003

0

302

1

97

302

98

Nasser 2016

0

235

0

119

235

119

b = 0.0001, 0.001, 0.01, and 0.1. We consider the following five  values: 0.001, 0.005, 0.01, 0.05, and 0.1. Under
the study homogeneity assumption, the probabilities of
the treatment group p1 are then obtained as pi1 = pi0 +.
Table 4 presents coverage and average length comparison between the five intervals when p0 ∼ U(0, 0.01%).
Coverage probabilities of the F interval range from 89% to
96%. The R interval is very conservative when  is small,
and its coverage is below 95% when  is larger. The Tian
interval is conservative when  ≤ 1%, but it could be as
low as 76% when  is 10%. The proposed accurate intervals always have the coverage probabilities close to the
nominal level as compared to the existing intervals. Average length is always an increasing function of  for each
confidence interval method. The Tian intervals are wider
than others when they all guarantee the coverage probability. The IS-R interval generally has a shorter length as
compared to the R interval and the IS-F intervals.

When the event rates of the control group are higher
with p0 ∼ U(0, 0.1%) in Fig. 2, the F interval generally performs better than others with regards to coverage probability and average length. When  is large (e.g., 10%),
coverage probabilities of these intervals are all slightly
below 95%. In this case with a small p0 and a relatively
large , the proposed intervals (IS-R or IS-F intervals)
have better coverage probabilities than the F interval, and
the length difference between the accurate intervals and
the F interval is small. When  = 10%, the coverage probability of the Tian interval is below 80%. When the rates
are even higher with p0 ∼ U(0, 1%), the rates are not rare
in these configurations, and the F interval outperforms
others as seen in Fig. 2.
Heterogeneity of study effects

Under the study heterogeneity assumption, the probability in the treatment group is pi1 =pi0 + ui , where ui is

Table 3 Confidence intervals for risk difference between the LAI-AP group and the OAP group
Asymptotic intervals

IS intervals

Tian interval

Method




lower

upper

length

lower

upper

length

Fixed-effects

-0.064%

-0.346%

0.218%

0.564%

-0.506%

0.165%

0.704%

Random-effects

-0.030%

-0.382%

0.322%

0.671%

-0.509%

0.250%

0.758%

Tian method

-0.028%

lower

upper

length

-0.843%

0.430%

1.273%
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Fig. 1 Coverage probability of the five methods under the study homogeneity assumption, with fixed and common rate pi0 = p in the control group

Table 4 Coverage probability and average length comparison between the five intervals when p0 ∼ U(0,0.01%)
The F interval

0.1%
0.5%
1.0%
5.0%
10.0%

Coverage
0.890
0.932
0.949
0.949
0.962

Length
0.21%
0.47%
0.66%
1.45%
1.99%

The IS-F interval

The R interval

Coverage
0.968
0.970
0.958
0.946
0.962

Coverage
1.000
0.987
0.877
0.905
0.935

Length
0.36%
0.71%
0.83%
1.45%
2.00%

Length
0.63%
0.72%
0.84%
1.58%
2.15%

The IS-R interval

The Tian interval

Coverage
0.984
0.957
0.944
0.952
0.960

Coverage
0.987
0.997
0.994
0.903
0.730

Length
0.34%
0.67%
0.76%
1.46%
2.00%

Length
1.02%
1.10%
1.24%
1.52%
1.63%

Shan et al. BMC Medical Research Methodology
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Fig. 2 Coverage probability and average length comparison between the five intervals under the study homogeneity assumption, when the
probability of the control group p0 ∼ U(0 , 0.1%) and U(0 , 1%)

the random study effect that follows a normal distribution
with mean of  and standard deviation of /2. Figure 3
presents the coverage probability and average length comparison between the five intervals when p0 ∼ U(0, 0.01%),
U(0, 0.1%), and U(0, 1%). As  increases, the standard
deviation of the probabilities in the treatment group goes
up. When  is small, the F interval, the IS-R interval,
and the IS-F interval have the coverage probabilities closer
to the nominal level as compared to the R interval and
the Tian interval. Coverage probabilities of the F interval and the IS-F interval drop to almost 50% when  is

10%. The R interval generally has good coverage when 
is large. However, the R interval’s coverage probabilities
are very low when  = 1% in meta-analysis with rare
events (e.g., p0 ∼ U(0, 0.01%) or U(0, 0.1%)). The ISR interval has consistent good performance with regards
to coverage and length as compared to others in metaanalysis with rare events. Figure 3 also presents the results
when the event rates are not rare (e.g., p0 ∼ U(0, 1%)).
When  is large, the R interval and the IS-R interval
have better coverage probabilities than others. When variance of study effects is small (for the configurations with
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Fig. 3 Coverage probability and average length comparison between the five intervals under the study heterogeneity assumption, when p0 ∼ U(0 ,
0.01%), U(0 , 0.1%) and U(0 , 1%)

small  values), the F interval performs better where the
configurations are similar to the ones under the study
homogeneity assumption.

Conclusions
We propose using importance sampling to construct
confidence intervals for risk difference in meta-analysis
with rare events. The traditionally used F interval has

satisfactory performance with regards to coverage probability and interval length when the rate of events is not
rare under the study homogeneity assumption, but this
interval could have a very low coverage probability under
the study heterogeneity assumption. The IS-R interval
based on the asymptotic limits from the random-effects
model outperforms the existing intervals under the heterogeneity assumption. The IS intervals use the existing

Shan et al. BMC Medical Research Methodology
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asymptotic limits to order the sample space. Although
the asymptotic limits are computed from asymptotic
approaches whose performances are based on the approximation of the test statistic to the limiting distribution,
the order of these limits provides a useful information to
produce better IS limits.
The Tian interval often guarantees the coverage probability when the rates of both groups are rare, but that
interval could have the coverage probability below the
nominal level when  is large. Theoretically, the Tian
interval can be used as a designated statistic to order the
sample space. However, simulations are involved in the
Tian interval calculation that would significantly increase
the computational intensity of the proposed IS intervals.
In addition, the ordering of the sample space based on the
Tian interval may change as the number of simulations
being utilized. For these reasons, we do not include the IS
intervals based on the ordering by the Tian interval.

Discussion
The method by Buehler [13] to construct exact one-sided
confidence interval is ideal for binary outcome when the
size of the sample size is not too large that allows a full
enumeration of the sample space [16, 26–29]. However, it
is not feasible in meta-analysis as it is extremely difficult
to save the sample space under the unconditional framework with sample size in each treatment group fixed. If
the upper bound of the possible number of events can be
determined and the size of the sample size is not too large,
exact Buehler interval may be computed. Otherwise, an
efficient search algorithm should be developed to order
the sample space efficiently.
Exact confidence intervals are preferable for statistical
inference. However, it is often computationally intensive,
such as the aforementioned the exact interval by Buehler
[28, 30–32]. For these reasons, simulation based intervals
are proposed for use in practice, including the proposed
interval here, the Tian interval, and the interval based
on confidence distribution [24, 33–35]. It is still a big
challenge in exact meta-analysis by enumerating all possible data, which becomes a big data problem with the
requirement of huge memory and computational power.
In addition to risk difference, odd ratio and risk ratio
are also used to measure the treatment effect. For studies with zero events in one or both treatment groups, the
estimated risk difference is zero. However, the estimated
ratios could be infinity [17, 36–39]. In order to avoid this
issue, an arbitrary small number (e.g.,  =0.5, 1) is often
added to each cell in the data. The performance of the test
statistics is affected by the chosen small value [6, 40–42].
The added value  also raises the question of whether the
number of participants in a study should be nij or nij + 2.
We consider this as future work to study the IS intervals
for ratios.

Page 9 of 10

Abbreviations
GLMMS: Generalized linear mixed models; IS: Importance sampling; LAI-AP:
Long-acting injectable antipsychotics; OAP: Oral antipsychotics
Acknowledgements
We would like to thank the support from the supercomputing center at UNLV.
Authors’ contributions
The idea for the paper was originally developed by GS. GS computed the new
confidence interval for meta-analysis with rare binary outcome. GS, CB, and TJ
drafted the manuscript and approved the final version.
Funding
Shan’s research is partially supported by grants from the National Institute of
General Medical Sciences from the National Institutes of Health:
P20GM109025. Jiang’s work is supported by the National Natural Foundation
of China under grant 11971433, and the First Class Discipline of Zhejiang –A
(Zhejiang Gongshang University-Statistics).
Availability of data and materials
Not applicable. This is a manuscript to develop novel statistical approaches,
therefore, no real data is involved.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1 School of Statistics and Mathematics, and School of Business, Zhejiang
Gongshang University, Hangzhou, Zhejiang, China. 2 School of Mathematical
Sciences, Nankai University, Tianjin, China. 3 Epidemiology and Biostatistics
Program, School of Public Health, University of Nevada Las Vegas, Las Vegas,
USA.
Received: 26 September 2019 Accepted: 17 March 2020

References
1. Vandermeer B, Bialy L, Hooton N, Hartling L, Klassen TP, Johnston BC,
Wiebe N. Meta-analyses of safety data: a comparison of exact versus
asymptotic methods. Stat Methods Med Res. 2009;18(4):421–32. https://
doi.org/10.1177/0962280208092559.
2. Mehta CR, Patel NR, Gray R. Computing an Exact Confidence Interval for
the Common Odds Ratio in Several 2 * 2 Contingency Tables. J Am Stat
Assoc. 1985;80(392):969–73. https://doi.org/10.1080/01621459.1985.
10478212.
3. Cai T, Parast L, Ryan L. Meta-analysis for rare events. Stat Med.
2010;29(20):2078–89. https://doi.org/10.1002/sim.3964.
4. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and
standard deviation from the sample size, median, range and/or
interquartile range. BMC Med Res Methodol. 2014;14(1):135. https://doi.
org/10.1186/1471-2288-14-135.
5. Mantel N, Haenszel W. Statistical Aspects of the Analysis of Data From
Retrospective Studies of Disease. JNCI J Natl Cancer Inst. 1959;22(4):
719–48. https://doi.org/10.1093/jnci/22.4.719.
6. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and
avoidance of continuity corrections in meta-analysis of sparse data. Stat
Med. 2004;23(9):1351–75. https://doi.org/10.1002/sim.1761.
7. Rücker G, Schwarzer G, Carpenter J, Olkin I. Why add anything to
nothing? The arcsine difference as a measure of treatment effect in
meta-analysis with zero cells. Stat Med. 2009;28(5):721–38. https://doi.
org/10.1002/sim.3511.
8. Kuss O. Statistical methods for meta-analyses including information from
studies without any events-add nothing to nothing and succeed
nevertheless. Stat Med. 2015;34(7):1097–116. https://doi.org/10.1002/sim.
6383.

Shan et al. BMC Medical Research Methodology

9.

10.
11.

12.

13.
14.

15.
16.
17.
18.

19.

20.
21.

22.

23.
24.

25.
26.

27.
28.

29.

30.

31.

32.

33.

(2020) 20:98

Tian L, Cai T, Pfeffer MA, Piankov N, Cremieux P-Y, Wei LJ. Exact and
efficient inference procedure for meta-analysis and its application to the
analysis of independent 2 x 2 tables with all available data but without
artificial continuity correction. Biostat (Oxford Engl). 2009;10(2):275–81.
https://doi.org/10.1093/biostatistics/kxn034.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials.
1986;7(3):177–88.
Schwarzer G, Carpenter JR, Rücker G. Meta-Analysis with R, Use R! Cham:
Springer; 2015. https://doi.org/10.1007/978-3-319-21416-0. http://link.
springer.com/10.1007/978-3-319-21416-0.
Bakbergenuly I, Kulinskaya E. Meta-analysis of binary outcomes via
generalized linear mixed models: A simulation study. BMC Med Res
Methodol. 2018;18(1):70. https://doi.org/10.1186/s12874-018-0531-9.
Buehler RJ. Confidence intervals for the product of two binomial
parameters. J Am Stat Assoc. 1957;52(280):482–93.
Kabaila P, Lloyd CJ. The efficiency of Buehler confidence limits. Stat
Probab Lett. 2003;65(1):21–8. https://doi.org/10.1016/s01677152(03)00215-3.
Kabaila P, Lloyd CJ. Buehler confidence limits and nesting. Aust N Z J Stat.
2004;46(3):463–9. https://doi.org/10.1111/j.1467-842x.2004.00343.x.
Kabaila P. Computation of exact confidence limits from discrete data.
Comput Stat. 2005;20(3):401–14. https://doi.org/10.1007/bf02741305.
Shan G. Exact Statistical Inference for Categorical Data, 1st edn. San
Diego: Academic Press; 2015. http://www.worldcat.org/isbn/0081006810.
Lloyd CJ, Li D. Computing highly accurate confidence limits from discrete
data using importance sampling. Stat Comput. 2014;24(4):663–73.
https://doi.org/10.1007/s11222-013-9409-1.
Kabaila P, Lloyd CJ. Profile upper Confidence Limits from Discrete Data.
Aust N Z J Stat. 2000;42(1):67–79. https://doi.org/10.1111/1467-842X.
00108.
Garthwaite PH, Buckland ST. Generating Monte Carlo confidence intervals
by the Robbins– Monro process. J Comput Graph Stat. 1992;41(1):159–71.
Garthwaite PH, Jones MC. A stochastic approximation method and its
application to confidence intervals. Journal of Computational and
Graphical Statistics. 2009;18(1):184–200.
Viechtbauer W. Conducting Meta-Analyses in <i>R</i> with the
<b>metafor</b> Package. J Stat Softw. 2010;36(3):1–48. https://doi.org/
10.18637/jss.v036.i03.
Lloyd CJ. Accurate confidence limits for stratified clinical trials. Stat Med.
2013;32(20):3415–23. https://doi.org/10.1002/sim.5809.
Yang G, Liu D, Wang J, Xie MG. Meta-analysis framework for exact
inferences with application to the analysis of rare events. Biometrics.
2016;72(4):1378–86. https://doi.org/10.1111/biom.12497.
Efthimiou O. Practical guide to the meta-analysis of rare events. Evid Based
Ment Health. 2018;21(2):72–6. https://doi.org/10.1136/eb-2018-102911.
Kabaila P, Lloyd CJ. Tight upper confidence limits from discrete data. Aust
J Stat. 1997;39(2):193–204. https://doi.org/10.1111/j.1467-842X.1997.
tb00535.x.
Kabaila Paul. Better Buehler confidence limits. Stat Probab Lett.
2001;52(2):145–54.
Shan G, Banks S, Miller JB, Ritter A, Bernick C, Lombardo J, Cummings
JL. Statistical advances in clinical trials and clinical research. Alzheimers
Dement Transl Res Clin Interv. 2018;4:366–71.
Shan G. Exact confidence limits for the probability of response in
two-stage designs. Statistics. 2018;52(5):1086–95. https://doi.org/10.
1080/02331888.2018.1469023.
Shan G. Exact Tests for Disease Prevalence Studies With Partially Validated
Data. Stat Biopharm Res. 20191–14. https://doi.org/10.1080/19466315.
2018.1555099.
Shan G. Exact confidence limits for the response rate in two-stage
designs with over or under enrollment in the second stage. Stat Methods
Med Res. 2018;27(4):1045–55.
Zhang H, Shan G. Letter to Editor: A novel confidence interval for a single
proportion in the presence of clustered binary outcome data. Stat
Methods Med Res. 2019096228021984005. https://doi.org/10.1177/
0962280219840056.
Liu D, Liu RY, ge Xie M. Exact Meta-Analysis Approach for Discrete Data
and its Application to 2 2 Tables With Rare Events. J Am Stat Assoc.
2014;109(508):1450–65. https://doi.org/10.1080/01621459.2014.946318.

Page 10 of 10

34. Shan G, Ma C, Hutson AD, Wilding GE. Randomized Two-Stage Phase II
Clinical Trial Designs Based on Barnard’s Exact Test. J Biopharm Stat.
2013;23(5):1081–90. https://doi.org/10.1080/10543406.2013.813525.
35. Shan G, Zhang H, Jiang T. Minimax and admissible adaptive two-stage
designs in phase II clinical trials. BMC Med Res Methodol. 2016;16(1):90.
https://doi.org/10.1186/s12874-016-0194-3.
36. Shan G, Hutson AD, Wilding GE. Two-stage k-sample designs for the
ordered alternative problem. Pharm Stat. 2012;11(4):287–94. https://doi.
org/10.1002/pst.1499.
37. Shan G, Ma C, Hutson AD, Wilding GE. Some tests for detecting trends
based on the modified Baumgartner-Weiß-Schindler statistics. Comput
Stat Data Anal. 2013;57(1):246–61. https://doi.org/10.1016/j.csda.2012.04.
021.
38. Shan G, Wilding GE. Powerful Exact Unconditional Tests for Agreement
between Two Raters with Binary Endpoints. PLoS ONE. 2014;9(5):97386.
https://doi.org/10.1371/journal.pone.0097386.
39. Shan G, Wilding GE, Hutson AD, Gerstenberger S. Optimal adaptive
two-stage designs for early phase II clinical trials. Stat Med. 2016;35(8):
1257–66. https://doi.org/10.1002/sim.6794.
40. Shan G, Kang L, Xiao M, Zhang H, Jiang T. Accurate unconditional
p-values for a two-arm study with binary endpoints. J Stat Comput Simul.
2018;88(6):1200–10.
41. Shan G. Comments on ’Two-sample binary phase 2 trials with low type I
error and low sample size’. Stat Med. 2017;36(21):3437–8. https://doi.org/
10.1002/sim.7359.
42. Shan G, Gerstenberger S. Fisher’s exact approach for post hoc analysis of
a chi-squared test. PLoS ONE. 2017;12(12):0188709. https://doi.org/10.
1371/journal.pone.0188709.

Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.

